Literature DB >> 16939673

Treatment of athletes with cardiac disease or arrhythmias.

Amil M Shah1, N A Mark Estes, Jonathan Weinstock, Munther K Homoud, Mark S Link.   

Abstract

Ventricular arrhythmias and sudden cardiac death in the athlete are uncommon but extremely visible because of the high profile of amateur and professional athletes. In athletes under the age of 30 years, the incidence of sudden death is low and in most cases occurs in individuals with inherited heart disease. In the older athlete, sudden death is more common and is generally due to arrhythmias in the context of coronary artery disease. Many athletes with aborted sudden death, arrhythmia-related syncope, or high-risk genetic disorders benefit from therapy with implantable cardioverter-defibrillators (ICDs). Although ICD therapy can effectively abort sudden death, implantation of an ICD generally prohibits an individual from all competitive athletics except low-intensity sports. Recommendations for participation in competitive athletics generally follow the recently published 36th Bethesda Conference Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities.

Entities:  

Year:  2006        PMID: 16939673     DOI: 10.1007/s11936-006-0039-1

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  50 in total

Review 1.  Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy.

Authors:  Michael P Frenneaux
Journal:  Heart       Date:  2004-05       Impact factor: 5.994

2.  Twenty-four hour continuous ECG recordings in long-distance runners.

Authors:  D A Talan; R A Bauernfeind; W W Ashley; C Kanakis; K M Rosen
Journal:  Chest       Date:  1982-07       Impact factor: 9.410

3.  Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.

Authors:  P J Schwartz; S G Priori; C Spazzolini; A J Moss; G M Vincent; C Napolitano; I Denjoy; P Guicheney; G Breithardt; M T Keating; J A Towbin; A H Beggs; P Brink; A A Wilde; L Toivonen; W Zareba; J L Robinson; K W Timothy; V Corfield; D Wattanasirichaigoon; C Corbett; W Haverkamp; E Schulze-Bahr; M H Lehmann; K Schwartz; P Coumel; R Bloise
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

Review 4.  Cardiovascular risks to young persons on the athletic field.

Authors:  B J Maron
Journal:  Ann Intern Med       Date:  1998-09-01       Impact factor: 25.391

5.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

6.  Screening for hypertrophic cardiomyopathy in young athletes.

Authors:  D Corrado; C Basso; M Schiavon; G Thiene
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

Review 7.  Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases.

Authors:  Barry J Maron; Bernard R Chaitman; Michael J Ackerman; Antonio Bayés de Luna; Domenico Corrado; Jane E Crosson; Barbara J Deal; David J Driscoll; N A Mark Estes; Claudio Gil S Araújo; David H Liang; Matthew J Mitten; Robert J Myerburg; Antonio Pelliccia; Paul D Thompson; Jeffrey A Towbin; Steven P Van Camp
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

8.  The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes.

Authors:  A Pelliccia; B J Maron; A Spataro; M A Proschan; P Spirito
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

9.  An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis)

Authors:  M S Link; P J Wang; N G Pandian; S Bharati; J E Udelson; M Y Lee; M A Vecchiotti; B A VanderBrink; G Mirra; B J Maron; N A Estes
Journal:  N Engl J Med       Date:  1998-06-18       Impact factor: 91.245

10.  Natural history of Brugada syndrome: insights for risk stratification and management.

Authors:  Silvia G Priori; Carlo Napolitano; Maurizio Gasparini; Carlo Pappone; Paolo Della Bella; Umberto Giordano; Raffaella Bloise; Carla Giustetto; Roberto De Nardis; Massimiliano Grillo; Elena Ronchetti; Giovanna Faggiano; Janni Nastoli
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

View more
  1 in total

Review 1.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.